Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.

Philipp JurmeisterMichael BockmayrChristoph TreeseUlrike SteinDido LenzeKorinna JöhrensFranziska FriedlingManfred DietelFrederick KlauschenWolfgang MarschEckhard FiedlerMaximilian von Laffert

Published in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2020)

Combined immunohistochemical analysis of Bcl-2, nuclear S100A4, Ki67 and MITF could contribute to better risk stratification of early-stage malignant melanoma patients.

Keyphrases

early stage
end stage renal disease
newly diagnosed
chronic kidney disease
neoadjuvant chemotherapy
peritoneal dialysis
sentinel lymph node
lymph node
basal cell carcinoma